Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer. Tolaney SM, Jiang Z, Zhang Q, Barroso-Sousa R, et al. N Engl J Med 2025 Oct 29. doi: 10.1056/NEJMoa2508668.

Read + Share

Amedeo Smart

Independent Medical Education

Tolaney SM, Jiang Z, Zhang Q, Barroso-Sousa R, et al. Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer. N Engl J Med 2025 Oct 29. doi: 10.1056/NEJMoa2508668.
PMID: 41160818